UTIDE BIOTECH (SHENZHEN)CO., LIMITED

Utide is a specialized manufacturer of GLP-1 peptide APIs, operating 20,000 square meters of manufacturing space in Zunyi, Guizhou, China. Backed by a core team with more than 20 years of experience in peptide R&D, process development and GMP-oriented manufacturing, Utide holds strong capabilities in route development, process optimization and rapid scale-up across a wide range of high-demand peptide products. With its Phase II facility now online, total annual production capacity is expected to reach 1,500-1,800 kg this year, supporting reliable, scalable long-term supply. The company has secured U.S. FDA Drug Master Files for tirzepatide (DMF No. 042984) and retatrutide (DMF No. 043330), with further global regulatory filings underway. Melos serves as Utide's exclusive strategic partner and commercial entity for Southeast and South Asia, acting as the core platform for Utide's international business development in those markets. Backed by a team with extensive international business and supply chain experience, Melos specializes in providing professional supply solutions and integrated commercial support for GLP-1 peptide APIs, handling regional contract execution, payment settlement, logistics coordination and customer support to ensure smooth, reliable and compliant delivery of Utide's peptide APIs throughout the region.